High performance liquid chromatography profiling with mass spectrometry detection was applicable to identify known and novel multidrug-resistance glycolipid inhibitors from the complex resin glycosides mixture of Ipomoea alba L., Convolvulaceae, seeds. Albinosides X and XI were purified by recycling liquid chromatography and their structural elucidation was accomplished by nuclear magnetic resonance. Albinoside XI exerted a strong potentiation of vinblastine susceptibility in multidrug-resistant human breast carcinoma cells.
Introduction
Ipomoea alba L., Convolvulaceae, or moon vine, is a nightblooming morning glory native to tropical Americas (McDonald, 1994) . In Mexico, the decoction of the leaves has been used for the treatment of paralysis and swelling of tissues (Lim, 2014) . This species is an ornamental plant but it has also been reported its invasive potential (Foxcroft et al., 2008) .
Previously, eleven resin glycosides were isolated from moon vine, calonyctins A 1 and A 2 from EtOH-soluble extracts of dried leaves (Fang et al., 1993) and albinosides I-IX from CHCl 3 -soluble extracts of seeds (Cruz-Morales et al., 2012 , 2016 . Resin glycosides are complex mixtures of oligosaccharides of monohydroxy and dihydroxy C-14 and C-16 fatty acids, which represent distinctive secondary metabolites restricted to the morning glory family (Pereda-Miranda et al., 2010) . These mixtures of glycolipids are a source of efflux pumps modulators responsible for the multidrug resistant (MDR) phenotype in Gram-positive (PeredaMiranda et al., 2006) and -negative bacteria (Corona-Castañeda and Pereda-Miranda, 2012) , as well as in mammalian cancer cells . MDR phenotype is considered a major cause for the failure of anticancer agents. Thus, the use of efflux pump modulators co-administered with cytotoxic drugs results in a susceptibility equivalent to that of a sensitive cell in March 2015. Eight seeds were germinated and two seedlings were grown to maturity under the conditions previously described (Cruz-Morales et al., 2016) . Vouchers were deposited at the Arkansas State University Herbarium (STAR 027009).
Extraction and isolation
Maceration of dried powdered seeds (300 g) was performed at room temperature with CHCl 3 . Precipitation of the resin glycoside with MeOH was achieved from the CHCl 3 -soluble extract to obtain a white solid (4.5 g), which was washed with hexane. The precipitated solid was analyzed by HPLC using a reversedphase Symmetry C 18 column (Waters; 7 m, 19 × 300 mm), an isocratic elution with MeOH-CH 3 CN-H 2 O (5:4:1), and a flow rate of 4 ml/min with a sample injection of 500 l (concentration: 0.1 mg/l). The resulting chromatogram showed eleven resolved peaks (Fig. 1) . Eluates with t R values of 83.3 min (20.9 mg) and 147.1 min (18.3 mg) were collected by the heart cutting technique (Pereda-Miranda and Hernández-Carlos, 2002) . Each subfraction was independently reinjected and purified by recycling HPLC to achieve homogeneity after ten consecutive cycles by application of peak shaving technique (Pereda-Miranda and Hernández-Carlos, 2002 ) until overlapped minor impurities were separated: Symmetry C 18 column (Waters; 7 m, 19 × 300 mm) with an elution of MeOH-CH 3 CN-H 2 O (10:7:3) and a flow rate of 6 ml/min. These procedures allowed the purification of 1 (15.5 mg; t R 8.6 min) and 2 (13.5 mg; t R 10.7 min).
Albinoside 
Alkaline hydrolysis of compounds 1-2
Solutions of compounds 1 and 2 (10 mg for each sample), in 5% KOH-H 2 O (1 ml) were refluxed at 95 • C for 3 h. Then, the mixtures were acidified to pH 5.0 and extracted with CHCl 3 (2× 2.5 ml) and Et 2 O (2× 2.5 ml). The CHCl 3 -soluble layer was washed, dried over anhydrous Na 2 SO 4 , evaporated, and analyzed by GC-MS. Tiglic acid was detected as the only volatile product for compounds 1 and 2 (t R 6.95 min): m/z [M] + 100 (30), 73 (100), 55 (22). The aqueous layer was extracted with n-BuOH (10 ml) and concentrated. Hydrolysis of compound 1 afforded 12 (4.5 mg), and compound 2 yielded 13 (4.3 mg).
Albinosinic 
Sugar analysis
Compounds 12 and 13 (3 mg of each one) in 10 ml HCl 4 N were independently refluxed at 90 • C for 1 h. Then, mixtures were diluted with 2.5 mL H 2 O and extracted with ether (2 × 5 ml). The organic layer was evaporated, re-suspended in CHCl 3 (3 ml), and alkylated with CH 2 N 2 . The aqueous layer was neutralized with KOH 1 N and extracted with n-BuOH (10 ml), then washed with H 2 O (2 × 5 ml) and concentrated. The thiazolidine derivatives of each mixture were prepared according to previously described procedures (Cruz-Morales et al., 2016) . These mixtures were treated with chlorotrimethylsilane (Sigma Sil-A) and analyzed by GC-MS (Cruz-Morales et al., 2016).
Identification of aglycones
The derivatized (CH 2 N 2 ) residues obtained from acid hydrolysis of 12 and 13 were analyzed by normal-phase HPLC (Porasil, 3.9 × 300 mm, 10 m), using an elution [hexane-CHCl 3 -Me 2 CO (6:3:1)] and a flow rate of 1 ml/min to identify methyl (11S)-hydroxytetradecanoate (t R 18.0 min) from compound 1 and methyl (11S)-hydroxyhexadecanoate (t R 15.5 min) from compound 2 by comparison with authentic samples (Cruz-Morales et al., 2016) .
Cytotoxicity and modulation of multidrug-resistance assays
Cytotoxicity of compounds 1 and 2 was determined by using the SRB assay. Cell lines were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum and cultured at 37 • C in 5% CO 2 in air (100% humidity). MCF-7/Vin + cells were cultured in medium containing 0.192 g/ml vinblastine. A stock of MCF-7/Vin cells was also maintained in vinblastine-free medium (MCF-7/Vin -). Cells at log phase were treated in triplicate with test samples (0.2-25 g/ml) and incubated for 72 h. For the reversal effects, sensitive MCF-7 and MDR MCF-7/Vin cells were seeded into 96-well plates and treated with various concentrations of vinblastine (0.00064-10 g/ml) in the presence or absence of glycolipids (25 g/ml) for 72 h. The ability of glycolipids to potentiate vinblastine cytotoxicity was measured by calculating the IC 50 .
Results and discussion

HPLC profiling of the resin glycoside content and isolation of 1 and 2
Preparative reversed-phase HPLC-RI (refractive index detection), using the heart-cutting technique (Pereda-Miranda and Hernández-Carlos, 2002) , was used to separate eleven major constituents from the resin glycoside fraction of moon vine seeds (Fig. 1) . Profiling of this resin glycosides based on MS allowed dereplication to be performed after fractionation, which included drying and redissolution of the eluted fractions (Potterat and Hamburger, 2013) in order to identify known and novel compounds (Smyth et al., 2012) . Each collected peak was analyzed by ESIMS and FAB-MS in both positive and negative modes. Albinosides I-IX (3-11) were unambiguously identified by comparison of the fragmentation ions observed in negative mode FAB-MS (Cruz-Morales et al., 2012 , 2016 two previously unknown glycolipids with t R = 83.3 and 147.1 min (Fig. 1 ), which were named as albinoside X (1) and albinoside XI (2), respectively. Each new peak was recycled in HPLC to achieve chromatographic homogeneity, allowing the purification of compounds 1 and 2. Saponification of both natural products liberated 2-methyl-2-butenoic acid as the acylating group. The same sugar composition was obtained by acid hydrolysis of both compounds 12 and 13, l-rhamnose, d-quinovose, and d-fucose in the ratio 2:1:1. The NMR spectra of both natural products 1 and 2 were very similar (Table 2) . For 1, four anomeric protons were observed at ı H 4.77 (1H, d, J = 7.6 Hz; ı C 103.2, Qui-1); 5.89 (1H, brs; ı C 100.4, Rha-1); 5.29 (1H, d, J = 7.6 Hz; ı C 107.1, Fuc-1), 5.64 (1H, brs; ı C 99.9, Rha -1) in the HSQC spectra. The HSQC spectra registered for compound 2 was almost identical with four anomeric signal centered at ı H 4.75 (1H, d, J = 7.6 Hz; ı C 103.0, Qui-1); 5.88 (1H, brs; ı C 100.2, Rha-1); 5.30 (1H, d, J = 7.6 Hz; ı C 106.9, Fuc-1), 5.64 (1H, brs; ı C 99.8, Rha -1). The glycosylation sequence was established by the long-range heteronuclear coupling correlations ( 3 J CH ) in the HMBC spectra. For instance, key correlations were observed in compounds 1 and 2: (a) the connectivity between H-1 of the quinovose (1: ı H 4.77; 2: ı H 4.75) and C-11 of the fatty acid (1: ı C 81.7; 2: ı C 80.9); (b) H-2 of quinovose (1: ı H 4.44; 2: ı H 4.45) with C-1 of rhamnose (1: ı C 100.4; 2: ı C 100.2); (c) H-4 of rhamnose (1: 1 H NMR and 13 C NMR spectra data of albinosides X-XI (1-2) (400 MHz and 100 MHz, C5D5N, ı ppm, J in Hz). 3.66 (dd, J = 9.9, 9.9 Hz) 75.9 3.68 (dd, J = 9.9, 9.9 Hz) 75.6 5 3.86 (dq, J = 9.9, 6.5 Hz) 72. Chemical shifts ı are in ppm relative to TMS. Chemical shifts marked with an asterisk ( * ) indicate overlapped signals. Abbreviations: qui, quinovose; rha, rhamnose; fuc, fucose; conv, 11-hydroxytetradecanoyl; jal, 11-hydroxyhexadecanoyl; tga, tigloyl. ı H 4.32; 2: ı H 4.33) with C-1 of fucose (1: ı C 107.1; 2: ı C 106.9); and (d) H-3 of fucose (ı H 4.25) with C-1 of Rha (1: ı C 99.9; 2: ı C 99.8). Accordingly, the glycosidic acid for compound 1, named as albinosidic acid H (12), corresponded to (11S)-hydroxytetradecanoic acid
while the structure for albinosidic acid I (13), the glycosidic acid for compound 2, was characterized as (11S)-hydroxyhexadecanoic
For the natural products, the macrolactonization site was located by the 3 J CH correlations between H-3 (1: ı H 5.76; 2: ı H 5.75) of Rha with C-1 (1: ı C 173.2; 2: ␦ C 173.0) of the fatty acid in the HMBC spectrum. The tigloyl group linkages were at the same location on the oligosaccharide core for 1 and 2. Thus, H-2 (ı H 5.88) of Rha' correlated with the C-1 (1: ı C 168.2; 2: ı C 168.0) signal Table 3 Modulation of vinblastine cytotoxicity in drug sensitive MCF-7 and multidrug-resistant MCF-7/Vin by 1 and 2. , 2012, 2016 ), a modulation assay was used to identify chemosensitizers through the potentiation of vinblastine susceptibility by compounds 1 and 2 in MDR cells (MCF-7/Vin + cells), using the cytotoxicity screening with SRB. The reversal fold values (RF MCF-7/Vin+ ) are included in Table 3 . A moderate activity was displayed by the non-cytotoxic albinoside X (1) (RF 2.0) which was similar to that reported for albinosides I (3, RF 3.1), II (4, RF 2.6), V (7, RF 2.3), and VI (8, RF 2.1) (Cruz-Morales et al., 2012 , 2016 . Albinoside XI (2) was moderately active against various carcinoma cell lines, including the MCF-7/Vin + cells (IC 50 4-9 M). Consequently, its strong reversal activity (RF >2140.6) could be the result of an additive synergism between cytotoxicity and modulation of efflux pumps.
Conclusion
For the HPLC-MS profiling, low resolution FABMS in negative mode was used for recording the fragmentation pattern of each eluted fraction and pure compounds, since this is the only procedure among the soft ionization techniques that provides a clear sequence for the fragmentation along the oligosaccharide core. Peaks resulting from the anomeric cleavages in conjunction with those produced by eliminations of the esterifying residues are abundant. In consequence, the intensity for some of the deprotonated molecule ions [M-H] -was low. However, ESIMS provided highly abundant [M-H] -ions in negative mode, as well as adduct ion [M+Na] + detected in positive mode. Thus, this profiling based on HPLC-MS allowed the identification of novel compounds 1 and 2 as well as known compounds 3-11.
The unexpected susceptibility of the MDR MCF-7/Vin + cells to compound 2 could represent an example of collateral hypersensitivity, i.e., the MCF-7 strain, in adapting to vinblastine also acquired hypersensitivity to alternative cytotoxins as albinosides. Therefore, the additive synergism expressed in the reversal activity of 2 could be significant in therapy regimes with combination of anticancer drugs and deserves further studies. These results support the potential of resin glycosides as inhibitors of multidrug efflux pumps in mammalian cancer cells, where glycoprotein-P is the prevailing translocase responsible for the resistant phenotype.
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